KertDSabbathMDFACP

PubMed

• 5 citations
  A phase 1b expansion study of TAS-102 with oxaliplatin for refractory metastatic colorectal cancer.
  Michael Cecchini, Jeremy S. Kortmansky, Can Cui, Wei Wei, Jaykumar R. Thumar, Nataliya Volodymyrivna Uboha, Navid Hafez, Jill Lacy, Neal A. Fischbach, Kert D. Sabbath,...> ;Cancer. 2020 Dec 22
• 9 citations
  Measuring the Impact of Academic Cancer Network Development on Clinical Integration, Quality of Care, and Patient Satisfaction
  Anne C. Chiang, Jessica Lake, Naralys Sinanis, Debra S. Brandt, Jane Kanowitz, Wajih Zaheer Kidwai, Jeremy S. Kortmansky, Johanna LaSala, Jeffrey Orell, Kert D. Sabbat...> ;Journal of Oncology Practice. 2018 Dec 11
• 13 citations
  Identifying an early treatment window for predicting breast cancer response to neoadjuvant chemotherapy using immunohistopathology and hemoglobin parameters.
  Quing Zhu, Susan Tannenbaum, Scott H. Kurtzman, Patricia DeFusco, Andrew Ricci, Hamed Vavadi, Feifei Zhou, Chen Xu, Alex Merkulov, Poornima Hegde, Mark Kane, Liqun Wan...> ;Breast Cancer Research. 2018 Jun 14
• 13 citations
  Single-arm, neoadjuvant, phase II trial of pertuzumab and trastuzumab administered concomitantly with weekly paclitaxel followed by 5-fluoruracil, epirubicin, and cycl...
  Julia Foldi, Sarah S. Mougalian, Andrea Silber, Donald R. Lannin, Brigid K. Killelea, Anees B. Chagpar, Nina R. Horowitz, Courtney Frederick, Lawrence Rispoli, Trisha ...> ;Breast Cancer Research and Treatment. 2018 Feb 2
• 106 citations
  Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer
  C. Aggarwal, Neal J. Meropol, Cornelis J. A. Punt, Nicholas Iannotti, B. H. Saidman, Kert D. Sabbath, N. Y. Gabrail, Joel Picus, Michael A. Morse, Edith P. Mitchell, M...> ;Annals of Oncology. 2013 Feb 1
• 391 citations
  Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer.
  Steven J. Cohen, Cornelis J. A. Punt, Nicholas Iannotti, B. H. Saidman, Kert D. Sabbath, Nashat Y. Gabrail, Joel Picus, Michael A. Morse, Edith P. Mitchell, M. C. Mill...> ;Annals of Oncology. 2009 Jul 1
• 9 citations
  Clonogenic cells in acute myeloblastic leukaemia.
  Kert D. Sabbath, James D. Griffin> ;Scandinavian Journal of Haematology. 2009 Apr 24
• 1357 citations
  Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer
  Steven J. Cohen, Cornelis J A Punt, Nicholas Iannotti, B. H. Saidman, Kert D. Sabbath, Nashat Y. Gabrail, Joel Picus, Michael A. Morse, Edith P. Mitchell, M. Craig Mil...> ;Journal of Clinical Oncology. 2008 Jul 1
• 34 citations
  A phase 2 study of TZT-1027, administered weekly to patients with advanced non-small cell lung cancer following treatment with platinum-based chemotherapy.
  Gregory J. Riely, Shirish M. Gadgeel, Ivan Rothman, B. H. Saidman, Kert D. Sabbath, Kevie Feit, Mark G. Kris, Naiyer A. Rizvi> ;Lung Cancer. 2007 Feb 1
• Potentially curable neoplasms.
  Kert D. Sabbath, Alan B. Weitberg, Paul Calabresi> ;Disease-a-Month. 1986 Oct 1
• 179 citations
  Effects of recombinant human GM-CSF on proliferation of clonogenic cells in acute myeloblastic leukemia.
  James D. Griffin, Diane C. Young, Friedhelm Herrmann, Donald Wiper, Katharina Wagner, Kert D. Sabbath> ;Blood. 1986 May 1
• 26 citations
  Cytotoxic Murine Monoclonal Antibody LAM8 with Specificity for Human Small Cell Carcinoma of the Lung
  Rolf A. Stahel, Carl O'Hara, Mack Mabry, Robert Waibel, Kert D. Sabbath, Johnathan A. Speak, Samuel D. Bernal> ;Cancer Research. 1986 Apr 1
• 31 citations
  Differential Expression of HLA-DR Antigens in Subsets of Human CFU-GM
  James D. Griffin, Kert D. Sabbath, Friedhelm Herrmann, Peter Larcom, Kim E. Nichols, Mary M. Kornacki, H Levine, Stephen A. Cannistra> ;Blood. 1985 Oct 1
• 14 citations
  Selective cytotoxicity of murine monoclonal antibody LAM2 against human small-cell carcinoma in the presence of human complement: possible use for in vitro elimination...
  Rolf A. Stahel, Mack Mabry, Kert D. Sabbath, Jonathan A. Speak, Samuel D. Bernal> ;International Journal of Cancer. 1985 May 15
• 147 citations
  Heterogeneity of clonogenic cells in acute myeloblastic leukemia.
  Kert D. Sabbath, Edward D. Ball, Peter Larcom, R B Davis, James D. Griffin> ;The Journal of Clinical Investigation. 1985 Feb 1
• 338 citations
  A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells
  James D. Griffin, David C. Linch, Kert D. Sabbath, Peter Larcom, Stuart F. Schlossman> ;Leukemia Research. 1984 Jan 1
• Identification and purification of human erythroid progenitor cells by monoclonal antibody to the transferrin receptor (TU 67).
  Herrmann, F., Griffin, J. D., Sabbath, K. D., Oster, W., Wernet, P., Mertelsmann, R.> ;Blut. 1988 Apr
• Continuous-infusion cisplatin and bolus 5-fluorouracil in colorectal carcinoma.
  Posner, M. R., Belliveau, J. F., Weitberg, A. B., Sabbath, K., Wiemann, M. C., Cummings, F. J., Calabresi, P.> ;Cancer Treat Rep. 1987 Oct
• Combined modality preoperative therapy for unresectable rectal cancer.
  Percarpio, B., Bitterman, J., Sabbath, K., Alfano, F., Ruszkowski, R., Bowen, J.> ;Conn Med. 1992 Jan
• Effects of 1-beta-D-arabinofuranosylcytosine and phorbol ester on differentiation of human K562 erythroleukemia cells.
  Watanabe, T., Mitchell, T., Sariban, E., Sabbath, K., Griffin, J., Kufe, D.> ;Mol Pharmacol. 1985 Jun 01
• Join now to see all